Get in touch with us at
Who We Are
We Build Healthcare Companies
Who We Are (cont.)
We help our clients with their business planning, market analysis, segmentation, pricing models, and go-to-market strategies, and we equip them with the tools for sustained growth. We empower companies to thrive in a competitive market by refining business models, conducting KOL research to validate an opportunity, or integrating AI and digital health solutions.
Bringing a healthcare product to market requires more than innovation—it demands a structured approach. We help our clients conduct comprehensive market analysis and develop and implement strategies to support clinical and health economic validation to ensure successful adoption. Our expertise helps businesses reduce time to market, strengthen provider and payer relationships, and maximize ROI on pharma/biotech, medical device, and digital transformation investments.
At HealthPath Strategies, we are more than advisors—we are architects of success. We help businesses innovate, expand, and lead in the evolving healthcare landscape through agility, industry expertise, and data-driven decision-making. We don’t just support healthcare companies—we build them.
Jan D’Alvise, Managing Partner
Jan D’Alvise, a CEO, board director, and serial entrepreneur, has spent over 30 years transforming pharmaceutical, medical device, diagnostic, and healthcare AI companies. She has co-founded two companies, led the turnaround of three others, and raised more than $500 million in equity and strategic capital to drive commercial growth that led to successful exits.
Jan’s ability to identify market opportunities, drive operational excellence, and lead companies through critical growth phases has positioned her as a trusted advisor and transformational leader in the life sciences industry. Whether launching healthcare solutions, securing capital, or orchestrating strategic partnerships and high-value mergers and acquisitions, she brings a strategic vision grounded in execution. Her financial acumen has allowed her to build sustainable businesses in high-risk, high-reward environments.
Jan is currently an Independent Board Director at Spectral Medical, Inc. (EDT: TO), where she contributes to the Finance, Audit, and Compensation Committees, as the company seeks FDA approval for a break-through endotoxic septic shock treatment.
Most recently, Jan served as Acting CEO and Chair of the Board at RadioEye, Inc., an AI-based imaging company that enhances radiologists’ decision-making through histologically validated MRI images. Previously, as President & CEO of AcastiPharma (ACST: NASDAQ) for more than 7 years, she raised over $150 million, led the $80 million acquisition of Grace Therapeutics, and accelerated two rare disease drug programs from pre-IND to Phase 3 in 18 months.
Jan's executive career includes leadership roles at several public and private companies where she developed and orchestrated strategic growth strategies, turnarounds, and M&A transactions. Prior to Acasti, she was VP of Product Development and Program Director at Syntex and Roche, Co-Founder and COO of METRIKA, Co-Founder and CEO of NuGEN, CEO of Gish Biomedical, and CEO of the Sidney Kimmel Cancer Center (SKCC).
Beyond her executive roles, Jan is a highly regarded board member and startup advisor. She has served on numerous public and private boards, including Acasti, NuGEN, METRIKA, Gish, SKCC, San Diego Tech Coast Angels, The OBG Project, Pediatric Bioscience, Planned Parenthood, and Michigan Technological University’s Tech Fund Advisory Boards. She also mentors early-stage companies through San Diego CONNECT and the Cedars-Sinai Accelerator, guiding them in business strategy, commercialization, and fundraising.
Jan’s board and advisory experience extends beyond corporate governance to mentorship and strategic guidance. As a Partner at HealthPath Strategies, she continues to shape the next generation of biotech, medical device, and AI-driven companies, by helping them refine commercialization strategies, attract investors, and develop and launch innovative healthcare products and applications.
Jan holds a B.S. in Biochemistry from Michigan Technological University and has completed executive programs at Stanford and Wharton Business School.
📍 San Diego, CA
📧 Jan@healthpathstrategies.com
📞 (650) 315-6037
🔗 LinkedIn: Jan D’Alvise
Reo Carr, Partner
Reo Carr is a seasoned healthcare strategist, technology innovator, and media executive with a career spanning over 25 years. He is the founder and CEO of Research Group of Companies, LLC (RGOC), a healthcare digital services, market research, and media company specializing in technology solutions for healthcare organizations. At RGOC, Reo leads initiatives to provide cutting-edge technology services, digital media strategies, and platform development, positioning the firm as a trusted partner for healthcare organizations navigating complex industry landscapes and digital transformations. RGOC also delivers critical regulatory and business insights to healthcare professionals through its subsidiary, Physicians News Network.
Reo has been at the forefront of integrating artificial intelligence (AI) into clinical healthcare settings, leveraging AI to enhance patient care, streamline physician workflow, and improve diagnostic accuracy. His early involvement in AI-driven healthcare solutions has shaped RGOC’s approach to utilizing advanced technologies to address key industry challenges.
Reo’s extensive experience in healthcare includes working with US-based healthcare companies in an advisory role, assisting them in entering offshore markets such as Asia, Europe, and the Middle East. He has guided these companies in navigating regulatory challenges, establishing strategic partnerships, and launching ventures in new regions.
Outside of healthcare Research Group has served clients in taxation, media, aerospace, education, telecommunications, research and development, public advocacy, government contracting and agribusiness, Reo served on the boards of various healthcare technology and diagnostic companies, specializing in innovative patient care solutions and advancements in autism diagnostics. He was pivotal in guiding a cancer research center through a complex merger with a major medical discovery institute, a transaction exceeding $40 million in value.
Reo’s commitment to the healthcare sector is further reflected in his role as a public speaker and moderator of healthcare forums. He has led roundtable discussions featuring hospital executives and healthcare professionals, providing strategic insights on industry trends.
Reo holds bachelor’s and master’s degrees from San Jose State University and completed post-graduate work at Stanford University. He resides in San Diego, California, and remains committed to advancing healthcare through innovation, strategic partnerships, and global market expansion.